Russell W J, Fenwick D G
Department of Anaesthesia and Intensive Care, Royal Adelaide Hospital, South Australia.
Anaesth Intensive Care. 2002 Aug;30(4):481-3. doi: 10.1177/0310057X0203000415.
A recent change from Haemaccel to Gelofusin as the preferred colloid for resuscitation in our region caused us to review patients who were known to be allergic to Haemaccel. As Gelofusin and Haemaccel are both modified gelatine, it seemed likely that cross reactivity could occur. Two patients who had been diagnosed previously as having had anaphylactic reactions to Haemaccel were tested intradermally with dilutions of 1/100 of Haemaccel and Gelofusin. Both patients showed similar positive reactions to each agent. It appears that patients who are known to be allergic to Haemaccel are probably allergic also to Gelofusin. Both patients have been given new Medic Alert bracelets stating "Allergic to Haemaccel and Gelofusin".
最近我们所在地区将复苏时首选的胶体液从贺斯改为佳乐施,这促使我们对已知对贺斯过敏的患者进行复查。由于佳乐施和贺斯都是改性明胶,似乎有可能发生交叉反应。两名先前被诊断为对贺斯有过敏反应的患者用1/100稀释度的贺斯和佳乐施进行了皮内试验。两名患者对每种制剂都表现出相似的阳性反应。看来已知对贺斯过敏的患者可能也对佳乐施过敏。这两名患者都已佩戴新的医疗警示手环,上面注明“对贺斯和佳乐施过敏”。